EUVIMEDEUVIMED entdecken
Open Access

Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts

Shan Luo, Qiaowa Gong, Yujie Ai, Jiayue Zhang, Linda Chan, William Chi Wai Wong, Patrick Ip, Esther Wai Yin Chan, Peter Tanuseputro, Ian Chi Kei Wong, Eric Yuk Fai Wan

JAMA Internal Medicine · 01.09.2026 · 186 (9) · 1102

DOI: 10.1001/jamainternmed.2026.2215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2026. Verfasst von Shan Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong …. Hauptthemen laut MEDLINE: Acetaminophen, Attention Deficit Disorder with Hyperactivity, Prenatal Exposure Delayed Effects, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Paracetamol (acetaminophen) is the first-line analgesic and antipyretic recommended globally during pregnancy. Observational studies have reported associations with increased risks of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in offspring, raising public and clinical concern; however, these findings may be substantially confounded by unmeasured familial factors.

Objectives

To assess the association between prenatal paracetamol exposure and risk of ASD and ADHD in offspring using a sibling-matched study design to control for familial confounding. Design, Setting, and Participants This population-based cohort study, conducted from January 1, 2001, to December 31, 2023, in Hong Kong, used deidentified electronic health records within a triangulation framework. From an initial cohort of 708 020 mother-child pairs (approximately 43.3% with prenatally paracetamol exposure), sibling-matched cohorts were constructed of children from families with discordant prenatal paracetamol exposure and sufficient follow-up (≥2 years for ASD and ≥5 years for ADHD). Data analysis was conducted from October 2, 2025, to March 24, 2026. Exposure Prenatal paracetamol exposure, identified from electronic dispensing records (British National Formulary [BNF], section 4.7.1) with data on drug name, strength, dosage, and prescription dates. Main Outcomes and Measures Incident diagnoses per the International Classification of Diseases, Ninth Revision, Clinical Modification, for ASD (code 299) or for ADHD (code 314) or a prescription for ADHD-specific medication licensed in Hong Kong (methylphenidate, atomoxetine, or lisdexamfetamine [BNF, section 4.4]).

Results

The final cohorts comprised 124 333 children for ASD analysis (mean [SD] age, 9.3 [4.7] years; 61 775 females [49.7%] and 62 558 males [50.3%]) and 97 285 for ADHD analysis (mean [SD] age, 7.6 [4.2] years; 48 455 females [49.8%], 48 830 [50.2%]). In the sibling-matched analyses, prenatal paracetamol exposure was not associated with the risk of ASD (adjusted hazard ratio [aHR], 1.00; 95% CI, 0.91-1.11) or ADHD (aHR, 1.01; 95% CI, 0.93-1.08). Null associations were consistent across exposure timing, cumulative dose, and usage patterns (sporadic, intermittent, persistent), and were robust in sensitivity analyses. However, positive associations were observed in conventional cohort analyses, and importantly, also in negative control analyses of prepregnancy exposure for ASD (HR, 1.12; 95% CI, 1.08-1.17) and ADHD (HR, 1.24; 95% CI, 1.20-1.28). Conclusions and Relevance In this population-based cohort study, a sibling-matched analysis found no evidence of an association between prenatal paracetamol exposure and the risk of ASD or ADHD in offspring. The positive signals observed in conventional studies are likely attributable to residual familial confounding. These findings provide important reassurance regarding the safety of indicated paracetamol use during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenAttention Deficit Disorder with HyperactivityPrenatal Exposure Delayed EffectsAnalgesics, Non-NarcoticAutism Spectrum DisorderAutistic DisorderHumansFemalePregnancyHong KongSiblingsChildMaleCohort StudiesChild, PreschoolAdult

Substanzen

AcetaminophenAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Family Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
  • The Bau Institute of Medical and Health Sciences Education, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.

Zitieren

APA

Luo, S., Gong, Q., Ai, Y., Zhang, J., Chan, L., Wong, W. C. W., Ip, P., Chan, E. W. Y., Tanuseputro, P., Wong, I. C. K., & Wan, E. Y. F. (2026). Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts. JAMA Internal Medicine, 186(9), 1102. https://doi.org/10.1001/jamainternmed.2026.2215

Vancouver

Luo S, Gong Q, Ai Y, Zhang J, Chan L, Wong WCW, et al. Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts. JAMA Internal Medicine. 2026;186(9):1102. doi:10.1001/jamainternmed.2026.2215

BibTeX
@article{Luo2026,
  author = {Luo, Shan and Gong, Qiaowa and Ai, Yujie and Zhang, Jiayue and Chan, Linda and Wong, William Chi Wai and Ip, Patrick and Chan, Esther Wai Yin and Tanuseputro, Peter and Wong, Ian Chi Kei and Wan, Eric Yuk Fai},
  title = {Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {9},
  pages = {1102},
  doi = {10.1001/jamainternmed.2026.2215}
}
Kostenlos starten →